CORE-008 ? BIOMEDICAL INFORMATICS SHARED RESOURCE (BISR) PROJECT SUMMARY / ABSTRACT The OSUCCC Biomedical Informatics Shared Resource (BISR) provides a comprehensive suite of services, technologies and expertise that collectively support the resource-efficient conduct of basic, clinical/translational and population science for OSUCCC investigators.
The Specific Aims of the BISR are: 1) to provide state-of- the-art bioinformatics and computational biology services for the analysis of massively parallel sequence data and the analysis of microarray datasets; 2) to provide OSUCCC investigators with services, expertise and access to technology platforms in support of heterogeneous and multi-dimensional biomedical data management requirements., The BISR, directed by Drs. Jeff Parvin (Aim 1) and Philip Payne (Aim 2), is supported through a combination of CCSG and project-specific grant funds (via charge-back mechanisms), as well as significant and ongoing institutional commitments of human, computational, and financial resources. During the prior five year grant period, the BISR was used by 45 OSUCCC members (59% of total users), but they accounted for 95.7% of usage. The BISR contributed to 195 publications, 29 with a journal impact factor greater than 10 and supported 21 NCI grants through billable services (charegebacks) (1 K12, 1 K24, 4 P01s, 2 P50s, 7 R01s, 1 R21, 1 R37, 1 RC2, 1 U01, 1 U10, and 1 U54). This is in addition to 18 BISR (Aim 1) staff members who have had directly funded appointments on NCI grants (i.e., 3 P01s, 2 P50s, 8 R01s, 1 R21, 1 RC2, 4 U01s, and 1 U54), other grants, and/or OSUCCC institutional funding sources. Through this work, BISR supported investigators from all five of the OSUCCC research programs. The BISR works closely and coordinates services with other OSUCCC shared resources, namely the Behavioral Measurement Shared Resource, the Genomics Shared Resource, the Biostatistics Shared Resource and the Biospecimen Services Shared Resource with its Total Care Cancer protocol. The future plans of the BISR are to streamline and strengthen existing next generation sequencing (NGS) data analysis pipelines through integration of new commercial programs, establish novel data visualization and visual analytics platforms, enhance the OSUCCC researchers abilities to access clinical data through an OSUCCC Information Warehouse serving as the honest broker and employing innovative electronic data capture tools, and fully implementing the Total Cancer Care protocol integration with other cancer centers for real time access to larger sets of electronic health records linked to biospecimens. The BISR leverages extensive institutional support and seeks only 7.0% support from CCSG funds. The Biomedical Informatics Shared Resource is part of the Analytics Grouping.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016058-42
Application #
9390846
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
42
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Kelly, Rachel S; Lasky-Su, Jessica; Yeung, Sai-Ching J et al. (2018) Integrative omics to detect bacteremia in patients with febrile neutropenia. PLoS One 13:e0197049
Straus, David J; Jung, Sin-Ho; Pitcher, Brandelyn et al. (2018) CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. Blood 132:1013-1021
Kim, Yangjin; Yoo, Ji Young; Lee, Tae Jin et al. (2018) Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy. Proc Natl Acad Sci U S A 115:4927-4932
Wang, Xinmei; Kwak, Kwang Joo; Yang, Zhaogang et al. (2018) Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma. PLoS One 13:e0198552
Callahan, Catherine L; Bonner, Matthew R; Nie, Jing et al. (2018) Lifetime exposure to ambient air pollution and methylation of tumor suppressor genes in breast tumors. Environ Res 161:418-424
Gopalakrishnan, Bhavani; Cheney, Carolyn; Mani, Rajeswaran et al. (2018) Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia. Oncotarget 9:9706-9713
Hankey, William; Frankel, Wendy L; Groden, Joanna (2018) Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev 37:159-172
Felix, A S; Brasky, T M; Cohn, D E et al. (2018) Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. Int J Cancer 142:1102-1115
Stover, Daniel G; Parsons, Heather A; Ha, Gavin et al. (2018) Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. J Clin Oncol 36:543-553
Jacobsen, Paul B; DeRosa, Antonio P; Henderson, Tara O et al. (2018) Systematic Review of the Impact of Cancer Survivorship Care Plans on Health Outcomes and Health Care Delivery. J Clin Oncol 36:2088-2100

Showing the most recent 10 out of 2602 publications